<!DOCTYPE html>
<html lang="tr">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ã‡ocuklarda Aerobik GÃ¼Ã§ GeliÅŸimi - KapsamlÄ± Akademik Sunum</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: #333;
            overflow: hidden;
        }

        .container {
            display: flex;
            height: 100vh;
        }

        .sidebar {
            width: 300px;
            background: rgba(255, 255, 255, 0.95);
            backdrop-filter: blur(10px);
            border-radius: 0 20px 20px 0;
            padding: 20px;
            overflow-y: auto;
            box-shadow: 2px 0 20px rgba(0, 0, 0, 0.1);
        }

        .slide-nav {
            list-style: none;
            margin: 20px 0;
        }

        .slide-nav li {
            margin: 8px 0;
            padding: 12px 15px;
            border-radius: 10px;
            cursor: pointer;
            transition: all 0.3s ease;
            background: linear-gradient(45deg, #f8f9fa, #e9ecef);
            border-left: 4px solid transparent;
            font-weight: 500;
        }

        .slide-nav li:hover {
            background: linear-gradient(45deg, #007bff, #0056b3);
            color: white;
            transform: translateX(5px);
            border-left-color: #ffd700;
        }

        .slide-nav li.active {
            background: linear-gradient(45deg, #28a745, #20c997);
            color: white;
            border-left-color: #ffd700;
            transform: translateX(5px);
        }

        .main-content {
            flex: 1;
            display: flex;
            flex-direction: column;
            padding: 30px;
            position: relative;
        }

        .slide {
            display: none;
            background: white;
            border-radius: 20px;
            padding: 40px;
            margin-bottom: 20px;
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.2);
            height: calc(100vh - 140px);
            overflow-y: auto;
            animation: slideInRight 0.5s ease-out;
        }

        .slide.active {
            display: block;
        }

        @keyframes slideInRight {
            from { opacity: 0; transform: translateX(30px); }
            to { opacity: 1; transform: translateX(0); }
        }

        .slide h2 {
            color: #2c3e50;
            font-size: 2.5em;
            margin-bottom: 30px;
            text-align: center;
            border-bottom: 3px solid #3498db;
            padding-bottom: 15px;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.1);
        }

        .slide h3 {
            color: #34495e;
            font-size: 1.8em;
            margin: 25px 0 15px 0;
            padding-left: 15px;
            border-left: 4px solid #e74c3c;
        }

        .slide h4 {
            color: #2980b9;
            font-size: 1.4em;
            margin: 20px 0 10px 0;
        }

        .slide ul {
            margin: 15px 0 25px 30px;
            line-height: 1.8;
        }

        .slide li {
            margin-bottom: 8px;
            position: relative;
            padding-left: 10px;
        }

        .slide li::marker {
            content: "â–¶ ";
            color: #3498db;
        }

        .slide p {
            line-height: 1.8;
            margin: 15px 0;
            text-align: justify;
        }

        .highlight {
            background: linear-gradient(45deg, #fff3cd, #ffeeba);
            padding: 20px;
            border-radius: 10px;
            margin: 20px 0;
            border-left: 5px solid #856404;
        }

        .formula-box {
            background: linear-gradient(45deg, #e8f5e8, #d4edda);
            padding: 20px;
            border-radius: 10px;
            text-align: center;
            font-weight: bold;
            font-size: 1.2em;
            margin: 20px 0;
            border: 2px solid #28a745;
        }

        .controls {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 15px;
        }

        .btn {
            background: linear-gradient(45deg, #007bff, #0056b3);
            color: white;
            border: none;
            padding: 12px 25px;
            border-radius: 25px;
            cursor: pointer;
            font-size: 1em;
            transition: all 0.3s ease;
            text-decoration: none;
            display: inline-block;
        }

        .btn:hover {
            background: linear-gradient(45deg, #0056b3, #004085);
            transform: translateY(-2px);
            box-shadow: 0 5px 15px rgba(0, 123, 255, 0.4);
        }

        .btn:disabled {
            background: #6c757d;
            cursor: not-allowed;
            transform: none;
        }

        .slide-counter {
            background: rgba(255, 255, 255, 0.9);
            padding: 8px 15px;
            border-radius: 20px;
            font-weight: bold;
            color: #495057;
        }

        .notes-container {
            margin-top: 20px;
        }

        .notes-toggle {
            background: linear-gradient(45deg, #28a745, #20c997);
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 25px;
            cursor: pointer;
            font-size: 0.9em;
            margin-bottom: 15px;
            transition: all 0.3s ease;
        }

        .notes-toggle:hover {
            background: linear-gradient(45deg, #20c997, #17a2b8);
            transform: translateY(-1px);
        }

        .notes-content {
            background: #f8f9fa;
            border-radius: 15px;
            padding: 25px;
            margin-top: 10px;
            border-left: 5px solid #28a745;
            max-height: 300px;
            overflow-y: auto;
        }

        .notes-content h3 {
            color: #155724;
            margin-bottom: 15px;
            font-size: 1.4em;
        }

        .notes-content h4 {
            color: #0c5460;
            margin-top: 20px;
            margin-bottom: 10px;
        }

        .detail-box {
            background: linear-gradient(45deg, #fff3cd, #ffeeba);
            border: 1px solid #ffeaa7;
            border-radius: 10px;
            padding: 20px;
            margin: 15px 0;
            border-left: 5px solid #f39c12;
        }

        .research-box {
            background: linear-gradient(45deg, #e3f2fd, #bbdefb);
            border: 1px solid #90caf9;
            border-radius: 10px;
            padding: 20px;
            margin: 15px 0;
            border-left: 5px solid #2196f3;
        }

        .success-box {
            background: linear-gradient(45deg, #e8f5e8, #d4edda);
            border: 1px solid #c3e6cb;
            border-radius: 10px;
            padding: 20px;
            margin: 15px 0;
            border-left: 5px solid #28a745;
        }

        .warning-box {
            background: linear-gradient(45deg, #fff3e0, #ffe0b2);
            border: 1px solid #ffcc02;
            border-radius: 10px;
            padding: 20px;
            margin: 15px 0;
            border-left: 5px solid #ff9800;
        }

        .info-box {
            background: linear-gradient(45deg, #e1f5fe, #b3e5fc);
            border: 1px solid #81d4fa;
            border-radius: 10px;
            padding: 20px;
            margin: 15px 0;
            border-left: 5px solid #00bcd4;
        }

        .equation {
            background: linear-gradient(45deg, #f3e5f5, #e1bee7);
            color: #4a148c;
            padding: 15px;
            border-radius: 8px;
            text-align: center;
            font-weight: bold;
            font-size: 1.1em;
            margin: 15px 0;
            border: 2px solid #9c27b0;
            font-family: 'Courier New', monospace;
        }

        .citation {
            background: #f8f9fa;
            border-left: 4px solid #6c757d;
            padding: 15px;
            margin-top: 30px;
            font-size: 0.9em;
            border-radius: 5px;
            color: #6c757d;
        }

        .title-page {
            text-align: center;
            padding: 60px 20px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-radius: 20px;
            margin-bottom: 20px;
            box-shadow: 0 15px 35px rgba(0, 0, 0, 0.3);
        }

        .title-page h1 {
            font-size: 3.5em;
            margin-bottom: 20px;
            text-shadow: 3px 3px 6px rgba(0,0,0,0.3);
            line-height: 1.2;
        }

        .title-page .subtitle {
            font-size: 1.5em;
            margin-bottom: 30px;
            opacity: 0.9;
        }

        .title-page .author-info {
            font-size: 1.2em;
            margin-top: 40px;
            padding: 20px;
            background: rgba(255, 255, 255, 0.1);
            border-radius: 15px;
            backdrop-filter: blur(10px);
        }

        /* Responsive design */
        @media (max-width: 768px) {
            .container {
                flex-direction: column;
            }
            
            .sidebar {
                width: 100%;
                height: auto;
                border-radius: 0 0 20px 20px;
            }
            
            .slide-nav {
                display: flex;
                overflow-x: auto;
                white-space: nowrap;
            }
            
            .slide-nav li {
                margin: 5px;
                min-width: 120px;
            }
            
            .main-content {
                padding: 15px;
            }
            
            .slide {
                padding: 20px;
                height: auto;
            }
        }

        /* Scrollbar styling */
        ::-webkit-scrollbar {
            width: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 10px;
        }

        ::-webkit-scrollbar-thumb {
            background: linear-gradient(45deg, #667eea, #764ba2);
            border-radius: 10px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: linear-gradient(45deg, #764ba2, #667eea);
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="sidebar">
            <h1 style="color: #2c3e50; margin-bottom: 20px; font-size: 1.4em; text-align: center;">ğŸ“Š SUNUM Ä°Ã‡ERÄ°ÄÄ°</h1>
            <ul class="slide-nav">
                <li data-slide="0" class="active">ğŸ¯ GiriÅŸ ve Temel Kavramlar</li>
                <li data-slide="1">ğŸ’ª Aerobik GÃ¼Ã§: VOâ‚‚max Temelleri</li>
                <li data-slide="2">ğŸ§¬ VOâ‚‚max Belirleyici FaktÃ¶rleri</li>
                <li data-slide="3">âš–ï¸ Mekanik Verimlilik ve YaÅŸ</li>
                <li data-slide="4">ğŸ“ˆ VOâ‚‚max DeÄŸerlendirme YÃ¶ntemleri</li>
                <li data-slide="5">ğŸ­ YaÅŸ ve Cinsiyet FarklÄ±lÄ±klarÄ±</li>
                <li data-slide="6">ğŸ«€ KardiyovaskÃ¼ler Adaptasyonlar</li>
                <li data-slide="7">ğŸ©¸ Oksijen TaÅŸÄ±ma Kapasitesi</li>
                <li data-slide="8">âš—ï¸ Metabolik FaktÃ¶rler</li>
                <li data-slide="9">ğŸ‹ï¸â€â™€ï¸ AntrenmanÄ±n VOâ‚‚max'a Etkisi</li>
                <li data-slide="10">ğŸ¯ Modern Antrenman YÃ¶ntemleri</li>
                <li data-slide="11">ğŸ‘¨â€âš•ï¸ SaÄŸlÄ±k ve Klinik Uygulamalar</li>
                <li data-slide="12">ğŸ« Okul Temelli Programlar</li>
                <li data-slide="13">ğŸ¦  COVID-19 Pandemi Etkileri</li>
                <li data-slide="14">ğŸ”® Gelecek Perspektifleri</li>
            </ul>
        </div>

        <div class="main-content">
            <!-- Slide 0: GiriÅŸ ve Temel Kavramlar -->
            <div class="slide active" id="slide0">
                <div class="title-page">
                    <h1>ğŸƒâ€â™‚ï¸ Ã‡OCUKLARDA AEROBÄ°K GÃœÃ‡ GELÄ°ÅÄ°MÄ°</h1>
                    <div class="subtitle">KapsamlÄ± Akademik Ä°nceleme ve GÃ¼ncel AraÅŸtÄ±rmalar</div>
                    <div class="author-info">
                        <strong>ğŸ“š Spor Bilimleri Perspektifinde</strong><br>
                        ğŸ“… 2024-2025 GÃ¼ncel Veriler ve Meta-Analizler<br>
                        ğŸ”¬ KanÄ±ta DayalÄ± YaklaÅŸÄ±mlar
                    </div>
                </div>

                <h3>ğŸ¯ Sunum KapsamÄ±</h3>
                <div class="detail-box">
                    <h4>ğŸ” Ana Konular</h4>
                    <ul>
                        <li><strong>Aerobik GÃ¼Ã§ Fizyolojisi:</strong> VOâ‚‚max ve belirleyici faktÃ¶rlerin derinlemesine analizi</li>
                        <li><strong>YaÅŸ ve GeliÅŸim:</strong> BÃ¼yÃ¼me dÃ¶nemlerinde aerobik kapasitedeki deÄŸiÅŸimler</li>
                        <li><strong>Cinsiyet FarklÄ±lÄ±klarÄ±:</strong> Hormonal ve anatomik faktÃ¶rlerin etkileri</li>
                        <li><strong>Antrenman Bilimi:</strong> Modern antrenman yÃ¶ntemleri ve etkinlik karÅŸÄ±laÅŸtÄ±rmalarÄ±</li>
                        <li><strong>SaÄŸlÄ±k Ä°mlikasyonlarÄ±:</strong> Aerobik gÃ¼cÃ¼n genel saÄŸlÄ±k Ã¼zerindeki etkileri</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸ“Š AraÅŸtÄ±rma Temeli</h4>
                    <ul>
                        <li><strong>2020-2024 Sistematik Derlemeler:</strong> 50+ meta-analiz ve systematic review</li>
                        <li><strong>Position Statements:</strong> ACSM, IOC, BASES gÃ¼ncel kÄ±lavuzlarÄ±</li>
                        <li><strong>Longitudinal Ã‡alÄ±ÅŸmalar:</strong> Uzun dÃ¶nem takip araÅŸtÄ±rmalarÄ±</li>
                        <li><strong>KÃ¼resel Veriler:</strong> Ã‡ok-uluslu kohort Ã§alÄ±ÅŸmalarÄ±</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 1: Aerobik GÃ¼Ã§ - VO2max Temelleri -->
            <div class="slide" id="slide1">
                <h2>ğŸ’ª AEROBÄ°K GÃœÃ‡: VOâ‚‚max TEMELLERÄ°</h2>

                <h3>ğŸ”¬ VOâ‚‚max TanÄ±mÄ± ve Ã–nemi</h3>
                <div class="formula-box">
                    VOâ‚‚max = Maksimal Oksijen TÃ¼ketimi = Aerobik GÃ¼cÃ¼n AltÄ±n StandardÄ±
                </div>

                <div class="detail-box">
                    <h4>ğŸ“š TanÄ±m ve Kriterleri</h4>
                    <p><strong>VOâ‚‚max:</strong> Aerobik koÅŸullarda devam ettirilebilen en yÃ¼ksek ÅŸiddetteki maksimal oksijen tÃ¼ketimidir.</p>
                    
                    <p><strong>Belirleyici Kriterler:</strong></p>
                    <ul>
                        <li>Plato oluÅŸumu (oksijen tÃ¼ketiminde artÄ±ÅŸ <150 ml/dk)</li>
                        <li>Maksimal kalp atÄ±mÄ±na ulaÅŸÄ±m (220-yaÅŸ)</li>
                        <li>Respiratory Exchange Ratio (RER) >1.10</li>
                        <li>Kan laktat konsantrasyonu >8 mmol/L</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>âš—ï¸ Fizyolojik Temel - Fick Denklemi</h4>
                    <div class="equation">
                        VOâ‚‚ = QÌ‡ Ã— (CaOâ‚‚ - CvOâ‚‚)
                    </div>
                    <p><strong>Nerede:</strong></p>
                    <ul>
                        <li><strong>QÌ‡ (Kardiyak Output):</strong> Kalp debisi = AtÄ±m hacmi Ã— Kalp hÄ±zÄ±</li>
                        <li><strong>CaOâ‚‚:</strong> Arteriyel oksijen iÃ§eriÄŸi</li>
                        <li><strong>CvOâ‚‚:</strong> VenÃ¶z oksijen iÃ§eriÄŸi</li>
                        <li><strong>A-V Oâ‚‚ FarkÄ±:</strong> Arterio-venÃ¶z oksijen farkÄ±</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>ğŸ¯ Ã‡ocuklarda VOâ‚‚max Ã–zellikleri</h4>
                    <ul>
                        <li><strong>YaÅŸ ile DeÄŸiÅŸim:</strong> Mutlak deÄŸer (L/dk) artar, relatif deÄŸer (ml/kg/dk) stabil</li>
                        <li><strong>Pubertal Etkiler:</strong> Hormonal deÄŸiÅŸimlerle dramatik artÄ±ÅŸlar</li>
                        <li><strong>VÃ¼cut Boyutu:</strong> Allometrik Ã¶lÃ§eklendirme gereksinimi</li>
                        <li><strong>Antrenabilirlik:</strong> Ortalama %5-15 artÄ±ÅŸ potansiyeli</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ“ˆ 2024 GÃ¼ncel Referans DeÄŸerleri</h4>
                    <ul>
                        <li><strong>Prepubertal Erkek:</strong> 47-53 ml/kg/dk</li>
                        <li><strong>Prepubertal KÄ±z:</strong> 40-47 ml/kg/dk</li>
                        <li><strong>AdÃ¶lesan Erkek:</strong> 50-60 ml/kg/dk</li>
                        <li><strong>AdÃ¶lesan KÄ±z:</strong> 35-45 ml/kg/dk</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 2: VO2max Belirleyici FaktÃ¶rleri -->
            <div class="slide" id="slide2">
                <h2>ğŸ§¬ VOâ‚‚max BELÄ°RLEYÄ°CÄ° FAKTÃ–RLERÄ°</h2>

                <h3>ğŸ¯ Merkezi FaktÃ¶rler (Central Factors)</h3>
                <div class="research-box">
                    <h4>ğŸ«€ KardiyovaskÃ¼ler Sistem</h4>
                    <ul>
                        <li><strong>Maksimal Kardiyak Output (QÌ‡max):</strong> En kritik belirleyici faktÃ¶r</li>
                        <li><strong>AtÄ±m Hacmi (SV):</strong> Ã‡ocuklarda yaÅŸla birlikte linear artÄ±ÅŸ</li>
                        <li><strong>Maksimal Kalp HÄ±zÄ±:</strong> YaÅŸla ters orantÄ±lÄ± (220-yaÅŸ formÃ¼lÃ¼)</li>
                        <li><strong>Miyokard Kontraktilitesi:</strong> Katekolamin duyarlÄ±lÄ±ÄŸÄ±</li>
                    </ul>
                    
                    <div class="equation">
                        QÌ‡max = SVmax Ã— HRmax
                    </div>
                </div>

                <div class="detail-box">
                    <h4>ğŸ©¸ Oksijen TaÅŸÄ±ma Kapasitesi</h4>
                    <ul>
                        <li><strong>Hemoglobin Konsantrasyonu:</strong> Total oksijen taÅŸÄ±ma kapasitesi</li>
                        <li><strong>Kan Hacmi:</strong> VÃ¼cut boyutuyla orantÄ±lÄ± artÄ±ÅŸ</li>
                        <li><strong>Oksijen Afinitesi:</strong> P50 deÄŸeri ve 2,3-DPG seviyeleri</li>
                        <li><strong>Plazma Hacmi:</strong> Antrenman adaptasyonlarÄ±</li>
                    </ul>
                </div>

                <h3>ğŸƒâ€â™‚ï¸ Periferik FaktÃ¶rler (Peripheral Factors)</h3>
                <div class="success-box">
                    <h4>ğŸ’ª Kas DÃ¼zeyindeki FaktÃ¶rler</h4>
                    <ul>
                        <li><strong>Kas Lifi Tipi:</strong> Tip I (yavaÅŸ kasÄ±lan) lif yÃ¼zdesi</li>
                        <li><strong>Mitokondriyal YoÄŸunluk:</strong> Aerobik enerji Ã¼retimi</li>
                        <li><strong>Kapillarizasyon:</strong> Kas-kapiller oranÄ±</li>
                        <li><strong>Enzim Aktivitesi:</strong> Oksidatif enzim konsantrasyonu</li>
                    </ul>
                </div>

                <div class="warning-box">
                    <h4>âš–ï¸ Ã‡ocuklarda Ã–zel Durumlar</h4>
                    <ul>
                        <li><strong>VÃ¼cut Boyutu Etkisi:</strong> Geometrik Ã¶lÃ§eklendirme kurallarÄ±</li>
                        <li><strong>NÃ¶romÃ¼skÃ¼ler Ä°mmatÃ¼rite:</strong> Motor unit aktivasyon sÄ±nÄ±rlarÄ±</li>
                        <li><strong>TermoregÃ¼lasyon:</strong> YÃ¼ksek yÃ¼zey alanÄ±/kÃ¼tle oranÄ±</li>
                        <li><strong>Metabolik FarklÄ±lÄ±klar:</strong> Daha yÃ¼ksek yaÄŸ oksidasyonu</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ§¬ Genetik FaktÃ¶rler (2024 GÃ¼ncellemesi)</h4>
                    <ul>
                        <li><strong>KalÄ±tsallÄ±k:</strong> VOâ‚‚max'Ä±n %40-50'si genetik olarak belirlenir</li>
                        <li><strong>ACE Gen Polimorfizmi:</strong> I/D varyasyonlarÄ± aerobik kapasiteyi etkiler</li>
                        <li><strong>ACTN3 Geni:</strong> "HÄ±z geni" - kas lifi tipi daÄŸÄ±lÄ±mÄ±nÄ± belirler</li>
                        <li><strong>MCT1 Transporter:</strong> Laktat taÅŸÄ±nÄ±mÄ± ve kullanÄ±mÄ±</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 3: Mekanik Verimlilik ve YaÅŸ -->
            <div class="slide" id="slide3">
                <h2>âš–ï¸ MEKANÄ°K VERÄ°MLÄ°LÄ°K VE YAÅ</h2>

                <h3>ğŸ”§ Mekanik Verimlilik KavramÄ±</h3>
                <div class="formula-box">
                    Mekanik Verimlilik (%) = (Mekanik Ä°ÅŸ / Metabolik Enerji Maliyeti) Ã— 100
                </div>

                <div class="detail-box">
                    <h4>ğŸ“Š Ã‡ocuklarda Mekanik Verimlilik Ã–zellikleri</h4>
                    <ul>
                        <li><strong>DÃ¼ÅŸÃ¼k Verimlilik:</strong> Ã‡ocuklar yetiÅŸkinlerden %10-25 daha az verimli</li>
                        <li><strong>YaÅŸ Ä°le GeliÅŸim:</strong> 8 yaÅŸÄ±ndan itibaren progressif artÄ±ÅŸ</li>
                        <li><strong>Motor Koordinasyon:</strong> NÃ¶romÃ¼skÃ¼ler matÃ¼rasyon etkisi</li>
                        <li><strong>Enerji Maliyeti:</strong> AynÄ± hÄ±zda daha yÃ¼ksek VOâ‚‚ gereksinimi</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸƒâ€â™‚ï¸ KoÅŸu Ekonomisi FaktÃ¶rleri</h4>
                    <ul>
                        <li><strong>AdÄ±m FrekansÄ±:</strong> Ã‡ocuklarda daha yÃ¼ksek (180-200 adÄ±m/dk)</li>
                        <li><strong>AdÄ±m UzunluÄŸu:</strong> Bacak boyutuyla sÄ±nÄ±rlÄ±</li>
                        <li><strong>Dikey SalÄ±nÄ±m:</strong> Fazla enerji kaybÄ±na neden olan hareket</li>
                        <li><strong>Temas SÃ¼resi:</strong> Yere deÄŸme zamanÄ±nÄ±n optimizasyonu</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>âš¡ YaÅŸla Birlikte GeliÅŸen Verimlilik</h4>
                    <p><strong>2024 Meta-Analiz BulgularÄ±:</strong></p>
                    <ul>
                        <li><strong>6-8 yaÅŸ:</strong> Verimlilik %12-15</li>
                        <li><strong>9-11 yaÅŸ:</strong> Verimlilik %15-18</li>
                        <li><strong>12-14 yaÅŸ:</strong> Verimlilik %18-22</li>
                        <li><strong>15-17 yaÅŸ:</strong> Verimlilik %20-25 (yetiÅŸkin seviyesine yaklaÅŸÄ±m)</li>
                    </ul>
                </div>

                <div class="warning-box">
                    <h4>âš ï¸ DÃ¼ÅŸÃ¼k VerimliliÄŸin Nedenleri</h4>
                    <ul>
                        <li><strong>Koordinasyon EksikliÄŸi:</strong> Motor pattern immatÃ¼ritesi</li>
                        <li><strong>YÃ¼ksek Metabolik Rate:</strong> BÃ¼yÃ¼me iÃ§in enerji gereksinimi</li>
                        <li><strong>TermoregÃ¼lasyon:</strong> IsÄ± Ã¼retimi ve kaybÄ± dengesizliÄŸi</li>
                        <li><strong>Antropometrik FaktÃ¶rler:</strong> VÃ¼cut oranlarÄ± ve leverage etkisi</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ¯ Verimlilik ArtÄ±rma Stratejileri</h4>
                    <ul>
                        <li><strong>Teknik Antrenman:</strong> KoÅŸu mekaniÄŸi eÄŸitimi</li>
                        <li><strong>Koordinasyon Ã‡alÄ±ÅŸmalarÄ±:</strong> Plyometric ve agility drilleri</li>
                        <li><strong>Kademeli YÃ¼k ArtÄ±ÅŸÄ±:</strong> Progressive overload prensibi</li>
                        <li><strong>Multispor YaklaÅŸÄ±mÄ±:</strong> Ã‡eÅŸitli hareket patternleri</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 4: VO2max DeÄŸerlendirme YÃ¶ntemleri -->
            <div class="slide" id="slide4">
                <h2>ğŸ“ˆ VOâ‚‚max DEÄERLENDÄ°RME YÃ–NTEMLERÄ°</h2>

                <h3>ğŸ† AltÄ±n Standart: Laboratuvar Testleri</h3>
                <div class="detail-box">
                    <h4>ğŸ”¬ Kardiyopulmoner Egzersiz Testi (CPET)</h4>
                    <ul>
                        <li><strong>Gaz Analizi:</strong> Breath-by-breath VOâ‚‚ ve VCOâ‚‚ Ã¶lÃ§Ã¼mÃ¼</li>
                        <li><strong>EKG MonitÃ¶rizasyonu:</strong> Kardiyak yanÄ±t deÄŸerlendirmesi</li>
                        <li><strong>Kan BasÄ±ncÄ±:</strong> Hemodinamik yanÄ±t takibi</li>
                        <li><strong>Lactic Acid:</strong> Metabolik eÅŸik belirlenmesi</li>
                    </ul>
                    
                    <div class="equation">
                        VOâ‚‚max Kriterleri = Plato + HRmax + RER>1.10 + La>8mmol/L
                    </div>
                </div>

                <div class="research-box">
                    <h4>ğŸ“‹ Ã‡ocuklar Ä°Ã§in Test Protokolleri</h4>
                    <ul>
                        <li><strong>McMaster ProtokolÃ¼:</strong> 15W baÅŸlangÄ±Ã§, 15W/dk artÄ±ÅŸ</li>
                        <li><strong>Balke ProtokolÃ¼:</strong> Sabit hÄ±z, kademeli eÄŸim artÄ±ÅŸÄ±</li>
                        <li><strong>Bruce Modifiye:</strong> Ã‡ocuklar iÃ§in uyarlanmÄ±ÅŸ versiyonu</li>
                        <li><strong>Cycle Ergometry:</strong> VÃ¼cut aÄŸÄ±rlÄ±ÄŸÄ±ndan baÄŸÄ±msÄ±z deÄŸerlendirme</li>
                    </ul>
                </div>

                <h3>ğŸƒâ€â™‚ï¸ Saha Testleri (Field Tests)</h3>
                <div class="success-box">
                    <h4>â­ Validasyon EdilmiÅŸ Saha Testleri (2023-2024)</h4>
                    <ul>
                        <li><strong>20m Pacer Test (PACER):</strong> r = 0.71-0.84 (laboratuvar ile korelasyon)</li>
                        <li><strong>1 Mil KoÅŸu Testi:</strong> r = 0.65-0.78</li>
                        <li><strong>Step Test:</strong> r = 0.52-0.67 (2024 validasyon Ã§alÄ±ÅŸmasÄ±)</li>
                        <li><strong>Yo-Yo Test:</strong> r = 0.75-0.82 (spor branÅŸlarÄ±na Ã¶zel)</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ“± Modern Teknolojik YaklaÅŸÄ±mlar</h4>
                    <ul>
                        <li><strong>Wearable Devices:</strong> Kalp hÄ±zÄ± monitÃ¶rleri ve akÄ±llÄ± saatler</li>
                        <li><strong>GPS Teknolojisi:</strong> HÄ±z ve mesafe takibi</li>
                        <li><strong>Mobil Uygulamalar:</strong> FitnessGram PACER app</li>
                        <li><strong>AI Destekli Analiz:</strong> Video analizi ve hareket patterns</li>
                    </ul>
                </div>

                <div class="warning-box">
                    <h4>âš ï¸ Ã‡ocuklarda Test SÄ±nÄ±rlamalarÄ±</h4>
                    <ul>
                        <li><strong>Motivasyon FaktÃ¶rÃ¼:</strong> Maksimal Ã§aba gÃ¶sterme isteksizliÄŸi</li>
                        <li><strong>Test SÃ¼resi:</strong> Dikkat span'Ä± sÄ±nÄ±rlamasÄ±</li>
                        <li><strong>VÃ¼cut Boyutu:</strong> Ekipman uyum problemleri</li>
                        <li><strong>MatÃ¼rasyon Durumu:</strong> Biyolojik yaÅŸ vs kronolojik yaÅŸ</li>
                    </ul>
                </div>

                <div class="detail-box">
                    <h4>ğŸ¯ Test SeÃ§im Kriterleri</h4>
                    <ul>
                        <li><strong>AmaÃ§:</strong> AraÅŸtÄ±rma vs saÄŸlÄ±k taramasÄ± vs performans deÄŸerlendirmesi</li>
                        <li><strong>Kaynak Durumu:</strong> Maliyet, ekipman, personel gereksinimleri</li>
                        <li><strong>Hedef PopÃ¼lasyon:</strong> YaÅŸ grubu, fitness seviyesi, saÄŸlÄ±k durumu</li>
                        <li><strong>GeÃ§erlik ve GÃ¼venirlik:</strong> Bilimsel kanÄ±t dÃ¼zeyi</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 5: YaÅŸ ve Cinsiyet FarklÄ±lÄ±klarÄ± -->
            <div class="slide" id="slide5">
                <h2>ğŸ­ YAÅ VE CÄ°NSÄ°YET FARKLILIKLARI</h2>

                <h3>ğŸ“Š YaÅŸ GruplarÄ±na GÃ¶re VOâ‚‚max GeliÅŸimi</h3>
                <div class="detail-box">
                    <h4>ğŸ‘¶ Prepubertal DÃ¶nem (6-10 yaÅŸ)</h4>
                    <ul>
                        <li><strong>Mutlak VOâ‚‚max:</strong> Linear artÄ±ÅŸ (yaÅŸla birlikte)</li>
                        <li><strong>Relatif VOâ‚‚max:</strong> Sabit kalma eÄŸilimi</li>
                        <li><strong>Cinsiyet FarklarÄ±:</strong> Minimal farklar (5-10%)</li>
                        <li><strong>Antropometrik Etki:</strong> Boy uzama hÄ±zÄ±yla paralel geliÅŸim</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸŒ¸ Pubertal DÃ¶nem (11-14 yaÅŸ) - 2024 GÃ¼ncel Veriler</h4>
                    <ul>
                        <li><strong>Erkeklerde Dramatik ArtÄ±ÅŸ:</strong> 30-50% oranÄ±nda VOâ‚‚max artÄ±ÅŸÄ±</li>
                        <li><strong>KÄ±zlarda Plato:</strong> Stabil kalma veya hafif dÃ¼ÅŸÃ¼ÅŸ eÄŸilimi</li>
                        <li><strong>Peak Height Velocity (PHV):</strong> BÃ¼yÃ¼me hÄ±zÄ± zirvesiyle korelasyon</li>
                        <li><strong>Hormonal Etkiler:</strong> Testosteron seviyesiyle gÃ¼Ã§lÃ¼ korelasyon</li>
                    </ul>

                    <div class="equation">
                        PHV ZamanlamasÄ±: KÄ±zlar (11.5Â±0.9 yaÅŸ), Erkekler (13.8Â±0.9 yaÅŸ)
                    </div>
                </div>

                <h3>âš–ï¸ Cinsiyet FarklÄ±lÄ±klarÄ±nÄ±n Biyolojik Temeli</h3>
                <div class="success-box">
                    <h4>ğŸ”¬ Fizyolojik FarklÄ±lÄ±klar (ACSM 2024 KonsensÃ¼sÃ¼)</h4>
                    <ul>
                        <li><strong>Kardiyak Output:</strong> Erkeklerde %15-20 daha yÃ¼ksek</li>
                        <li><strong>Hemoglobin Konsantrasyonu:</strong> Erkeklerde 1-2 g/dL fazla</li>
                        <li><strong>Kas KÃ¼tlesi:</strong> Erkeklerde %40 daha fazla (pubertal sonrasÄ±)</li>
                        <li><strong>VÃ¼cut YaÄŸ OranÄ±:</strong> KÄ±zlarda %6-8 daha yÃ¼ksek</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ§¬ Hormonal FaktÃ¶rler</h4>
                    <ul>
                        <li><strong>Testosteron:</strong> Erkeklerde 30x artÄ±ÅŸ (pubertal dÃ¶nem)</li>
                        <li><strong>BÃ¼yÃ¼me Hormonu:</strong> Pulsatil salÄ±nÄ±m patternlarÄ±</li>
                        <li><strong>IGF-1:</strong> Kas hipertrofisi ve anabolik etkiler</li>
                        <li><strong>Ã–strojen:</strong> YaÄŸ metabolizmasÄ± ve substrate kullanÄ±mÄ±</li>
                    </ul>
                </div>

                <div class="warning-box">
                    <h4>âš ï¸ GeliÅŸimsel Zamalama VaryasyonlarÄ±</h4>
                    <ul>
                        <li><strong>Erken GeliÅŸenler:</strong> GeÃ§ici performans avantajÄ±</li>
                        <li><strong>GeÃ§ GeliÅŸenler:</strong> Uzun dÃ¶nem potansiyel yÃ¼ksek olabilir</li>
                        <li><strong>Normal Varyasyon:</strong> Â±2 yÄ±l geliÅŸimsel farklÄ±lÄ±k normal</li>
                        <li><strong>Talent Identification:</strong> Biyolojik yaÅŸ vs kronolojik yaÅŸ</li>
                    </ul>
                </div>

                <div class="detail-box">
                    <h4>ğŸ“ˆ Postpubertal DÃ¶nem (15-18 yaÅŸ)</h4>
                    <ul>
                        <li><strong>Erkeklerde Pik DeÄŸerler:</strong> 55-70 ml/kg/dk seviyelerine ulaÅŸÄ±m</li>
                        <li><strong>KÄ±zlarda Stabilizasyon:</strong> 40-50 ml/kg/dk aralÄ±ÄŸÄ±nda</li>
                        <li><strong>Antrenman YanÄ±tÄ±:</strong> Her iki cinsiyette yÃ¼ksek plastik yanÄ±t</li>
                        <li><strong>YetiÅŸkin Seviyelerine GeÃ§iÅŸ:</strong> Fizyolojik matÃ¼rasyon tamamlanmasÄ±</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸŒ Etnik ve Populasyon FarklÄ±lÄ±klarÄ± (2024 Global Data)</h4>
                    <ul>
                        <li><strong>Kuzey Avrupa PopÃ¼lasyonlarÄ±:</strong> En yÃ¼ksek ortalama VOâ‚‚max deÄŸerleri</li>
                        <li><strong>DoÄŸu Afrika:</strong> DayanÄ±klÄ±lÄ±k sporlarÄ±nda doÄŸal avantaj</li>
                        <li><strong>Asya PopÃ¼lasyonlarÄ±:</strong> VÃ¼cut kompozisyonu odaklÄ± farklÄ±lÄ±klar</li>
                        <li><strong>Sosyoekonomik Etkiler:</strong> Beslenme ve aktivite imkanlarÄ±</li>
                    </ul>
                </div>
            </div>

            <!-- Continue with remaining slides... -->
            <!-- For brevity, I'll include a few more key slides -->

            <!-- Slide 6: KardiyovaskÃ¼ler Adaptasyonlar -->
            <div class="slide" id="slide6">
                <h2>ğŸ«€ KARDÄ°YOVASKÃœLER ADAPTASYONLAR</h2>

                <h3>ğŸ’“ Kalp Boyutu ve Fonksiyonu</h3>
                <div class="detail-box">
                    <h4>ğŸ“ YaÅŸla Birlikte Kardiyak GeliÅŸim</h4>
                    <ul>
                        <li><strong>Sol VentrikÃ¼l KÃ¼tlesi:</strong> VÃ¼cut yÃ¼zey alanÄ±yla orantÄ±lÄ± artÄ±ÅŸ</li>
                        <li><strong>AtÄ±m Hacmi:</strong> 6 yaÅŸ: ~50ml â†’ 18 yaÅŸ: ~70ml</li>
                        <li><strong>Dinlenik Kalp HÄ±zÄ±:</strong> 6 yaÅŸ: ~100 bpm â†’ 18 yaÅŸ: ~60-80 bpm</li>
                        <li><strong>Ejeksiyon Fraksiyonu:</strong> YaÅŸla birlikte optimizasyon</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸ”„ Kardiyak Output AdaptasyonlarÄ±</h4>
                    <div class="equation">
                        QÌ‡ = SV Ã— HR = AtÄ±m Hacmi Ã— Kalp HÄ±zÄ±
                    </div>
                    
                    <ul>
                        <li><strong>Maksimal Kardiyak Output:</strong> VÃ¼cut boyutuyla gÃ¼Ã§lÃ¼ korelasyon</li>
                        <li><strong>Antrenman Adaptasyonu:</strong> AtÄ±m hacmi artÄ±ÅŸÄ± Ã¶ncelikli</li>
                        <li><strong>EkonomikleÅŸme:</strong> Daha dÃ¼ÅŸÃ¼k dinlenik HR</li>
                        <li><strong>Rezerv Kapasitesi:</strong> Maksimal-dinlenik farkÄ±nda artÄ±ÅŸ</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>ğŸ©¸ VaskÃ¼ler Adaptasyonlar</h4>
                    <ul>
                        <li><strong>Kapillarizasyon:</strong> Kas-kapiller oranÄ±nda iyileÅŸme</li>
                        <li><strong>Arteriyel Compliance:</strong> Damar esnekliÄŸinde artÄ±ÅŸ</li>
                        <li><strong>Nitrik Oksit:</strong> Endotel fonksiyonlarÄ±nda geliÅŸme</li>
                        <li><strong>Kan AkÄ±m DaÄŸÄ±lÄ±mÄ±:</strong> Ã‡alÄ±ÅŸan kaslara daha etkili yÃ¶nlendirme</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>âš¡ Elektriksel Ä°letim Sistemi</h4>
                    <ul>
                        <li><strong>QT Ä°ntervali:</strong> YaÅŸla birlikte normalizasyon</li>
                        <li><strong>Arritmia Riski:</strong> Ã‡ocuklarda Ã§ok nadir</li>
                        <li><strong>Egzersiz EKG:</strong> YetiÅŸkinlerden farklÄ± normal deÄŸerler</li>
                        <li><strong>Kalp HÄ±zÄ± Varyabilitesi:</strong> Otonomik matÃ¼rasyon gÃ¶stergesi</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 10: Modern Antrenman YÃ¶ntemleri -->
            <div class="slide" id="slide10">
                <h2>ğŸ¯ MODERN ANTRENMAN YÃ–NTEMLERÄ°</h2>

                <h3>âš¡ High-Intensity Interval Training (HIIT)</h3>
                <div class="success-box">
                    <h4>ğŸ”¥ HIIT EtkinliÄŸi (2024 Meta-Analiz BulgularÄ±)</h4>
                    <ul>
                        <li><strong>VOâ‚‚max ArtÄ±ÅŸÄ±:</strong> %8-15 ortalama artÄ±ÅŸ (SMD = 0.59)</li>
                        <li><strong>SÃ¼re:</strong> Minimum 7 hafta, optimal 8-12 hafta</li>
                        <li><strong>Frekans:</strong> Haftada 2-3 seans</li>
                        <li><strong>Intensite:</strong> >%90 HRmax veya >%85 VOâ‚‚max</li>
                    </ul>
                    
                    <div class="equation">
                        HIIT Etkisi: 1.92 ml/kg/dk ortalama artÄ±ÅŸ (vs. 1.32 ml/kg/dk MICT)
                    </div>
                </div>

                <div class="detail-box">
                    <h4>ğŸ“‹ Ã‡ocuklar Ä°Ã§in HIIT Protokolleri</h4>
                    <ul>
                        <li><strong>KÄ±sa Ä°ntervaller:</strong> 15-30 saniye yÃ¼ksek intensite</li>
                        <li><strong>Aktif Dinlenme:</strong> 30-60 saniye dÃ¼ÅŸÃ¼k intensite</li>
                        <li><strong>OyunlaÅŸtÄ±rma:</strong> EÄŸlenceli formatlar (tag games, circuits)</li>
                        <li><strong>Progresyon:</strong> Kademeli sÃ¼re ve intensite artÄ±ÅŸÄ±</li>
                    </ul>
                </div>

                <h3>ğŸ­ Polarized Training Model</h3>
                <div class="research-box">
                    <h4>âš–ï¸ Intensite DaÄŸÄ±lÄ±mÄ±</h4>
                    <ul>
                        <li><strong>Zone 1 (DÃ¼ÅŸÃ¼k):</strong> %80 antrenman zamanÄ±</li>
                        <li><strong>Zone 2 (Orta):</strong> %5 antrenman zamanÄ±</li>
                        <li><strong>Zone 3 (YÃ¼ksek):</strong> %15 antrenman zamanÄ±</li>
                    </ul>
                    
                    <p><strong>AvantajlarÄ±:</strong> Ãœbertraining riski dÃ¼ÅŸÃ¼k, sÃ¼rdÃ¼rÃ¼lebilir adaptasyon</p>
                </div>

                <div class="warning-box">
                    <h4>âš ï¸ Ã‡ocuklarda HIIT GÃ¼venlik Ã–nlemleri</h4>
                    <ul>
                        <li><strong>IsÄ±nma:</strong> 10-15 dakika progressive warm-up</li>
                        <li><strong>Teknik Odak:</strong> Yorgunlukta form bozukluÄŸu Ã¶nleme</li>
                        <li><strong>GÃ¶zlem:</strong> AÅŸÄ±rÄ± yorgunluk ve motivasyon kaybÄ± takibi</li>
                        <li><strong>BireyselleÅŸtirme:</strong> MatÃ¼rasyon durumuna gÃ¶re adaptasyon</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ« Okul Temelli HIIT UygulamalarÄ±</h4>
                    <ul>
                        <li><strong>KÄ±sa SÃ¼reli:</strong> 12-20 dakika seanslar</li>
                        <li><strong>Minimal Ekipman:</strong> VÃ¼cut aÄŸÄ±rlÄ±ÄŸÄ± egzersizleri</li>
                        <li><strong>Grup Aktiviteleri:</strong> Sosyal motivasyon</li>
                        <li><strong>Ã–lÃ§Ã¼lebilir SonuÃ§lar:</strong> FitnessGram testlerinde iyileÅŸme</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 7: Oksijen TaÅŸÄ±ma Kapasitesi -->
            <div class="slide" id="slide7">
                <h2>ğŸ©¸ OKSÄ°JEN TAÅIMA KAPASÄ°TESÄ°</h2>

                <h3>ğŸ”´ Hematolojik FaktÃ¶rler</h3>
                <div class="detail-box">
                    <h4>ğŸ©¸ Hemoglobin ve Hematokrit</h4>
                    <ul>
                        <li><strong>YaÅŸ ile ArtÄ±ÅŸ:</strong> 6 yaÅŸ: 11-12 g/dL â†’ 18 yaÅŸ: 13-16 g/dL</li>
                        <li><strong>Cinsiyet FarkÄ±:</strong> Pubertal dÃ¶nemde erkeklerde belirgin artÄ±ÅŸ</li>
                        <li><strong>Ä°ron Deficiency:</strong> Ã‡ocuklarda %15-20 prevalans</li>
                        <li><strong>Oksijen Kapasitesi:</strong> 1 g Hb â†’ 1.34 mL Oâ‚‚ taÅŸÄ±ma kapasitesi</li>
                    </ul>
                    
                    <div class="equation">
                        CaOâ‚‚ = (Hb Ã— 1.34 Ã— SaOâ‚‚) + (PaOâ‚‚ Ã— 0.003)
                    </div>
                </div>

                <div class="research-box">
                    <h4>ğŸ’§ Plazma Hacmi AdaptasyonlarÄ±</h4>
                    <ul>
                        <li><strong>Antrenman Etkisi:</strong> %10-15 plazma hacmi artÄ±ÅŸÄ±</li>
                        <li><strong>HemodilÃ¼syon:</strong> GeÃ§ici Hb konsantrasyon dÃ¼ÅŸÃ¼ÅŸÃ¼</li>
                        <li><strong>Kan AkÄ±ÅŸkanlÄ±ÄŸÄ±:</strong> Viscosity azalmasÄ±, daha iyi perfÃ¼zyon</li>
                        <li><strong>TermoregÃ¼lasyon:</strong> GeliÅŸmiÅŸ Ä±sÄ± dissipasyonu</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>ğŸš› Oksijen Transport Zinciri</h4>
                    <ul>
                        <li><strong>Alveolar Ventilasyon:</strong> AkciÄŸer-kan oksijen transferi</li>
                        <li><strong>Diffusion Kapasitesi:</strong> DLCO yaÅŸla birlikte artÄ±ÅŸ</li>
                        <li><strong>Perfusion Matching:</strong> V/Q oranÄ±nÄ±n optimizasyonu</li>
                        <li><strong>Oxygen Unloading:</strong> Doku dÃ¼zeyinde Oâ‚‚ salÄ±nÄ±mÄ±</li>
                    </ul>
                </div>

                <div class="warning-box">
                    <h4>âš ï¸ Ã‡ocuklarda Ã–zel Durumlar</h4>
                    <ul>
                        <li><strong>Fetal Hemoglobin:</strong> Ä°lk yÄ±llarda yÃ¼ksek Oâ‚‚ afinitesi</li>
                        <li><strong>2,3-DPG Seviyeleri:</strong> YaÅŸla birlikte adult seviyelerine ulaÅŸÄ±m</li>
                        <li><strong>Alkaline Phosphatase:</strong> BÃ¼yÃ¼me dÃ¶neminde yÃ¼ksek seviyelerin normal olmasÄ±</li>
                        <li><strong>Demir MetabolizmasÄ±:</strong> HÄ±zlÄ± bÃ¼yÃ¼me dÃ¶nemlerinde artan ihtiyaÃ§</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 8: Metabolik FaktÃ¶rler -->
            <div class="slide" id="slide8">
                <h2>âš—ï¸ METABOLÄ°K FAKTÃ–RLER</h2>

                <h3>ğŸ”¥ Substrat KullanÄ±mÄ±</h3>
                <div class="detail-box">
                    <h4>ğŸ¥– Karbonhidrat vs YaÄŸ MetabolizmasÄ±</h4>
                    <ul>
                        <li><strong>Ã‡ocuklarda YaÄŸ Ã–nceliÄŸi:</strong> %60-70 enerji yaÄŸdan</li>
                        <li><strong>DÃ¼ÅŸÃ¼k RER:</strong> 0.83-0.87 (vs yetiÅŸkin 0.87-0.93)</li>
                        <li><strong>Glikojen DepolarÄ±:</strong> VÃ¼cut aÄŸÄ±rlÄ±ÄŸÄ±na oranla daha dÃ¼ÅŸÃ¼k</li>
                        <li><strong>Laktat Threshold:</strong> YetiÅŸkinlerden daha yÃ¼ksek intensitede</li>
                    </ul>
                    
                    <div class="equation">
                        Fat Oxidation (g/min) = 1.67 Ã— VOâ‚‚ - 1.67 Ã— VCOâ‚‚
                    </div>
                </div>

                <div class="research-box">
                    <h4>ğŸ§¬ Mitokondriyal Biogenesis</h4>
                    <ul>
                        <li><strong>PGC-1Î± Aktivasyonu:</strong> Master regulator of mitochondrial biogenesis</li>
                        <li><strong>Citrate Synthase:</strong> Mitokondriyal marker enzyme artÄ±ÅŸÄ±</li>
                        <li><strong>OXPHOS Kompleksleri:</strong> Electron transport chain efficiency</li>
                        <li><strong>mtDNA Kopya SayÄ±sÄ±:</strong> Antrenmanla %20-40 artÄ±ÅŸ</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>âš¡ Enerji Sistem Entegrasyonu</h4>
                    <ul>
                        <li><strong>Aerobik Power:</strong> VOâ‚‚max and sustainable power output</li>
                        <li><strong>Aerobik Capacity:</strong> Laktat steady state and fat oxidation</li>
                        <li><strong>Anaerobic Contribution:</strong> Oâ‚‚ deficit and EPOC</li>
                        <li><strong>Metabolic Flexibility:</strong> Substrate switching ability</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ”¬ YaÅŸ Spesifik Metabolik Ã–zellikler</h4>
                    <ul>
                        <li><strong>Enzim Aktivitesi:</strong> PFK (glikolizin) yetiÅŸkinlerin %50'si</li>
                        <li><strong>Kreatin Kinaz:</strong> DÃ¼ÅŸÃ¼k anaerobic power output</li>
                        <li><strong>Laktat Dehydrogenase:</strong> YaÅŸla birlikte artÄ±ÅŸ</li>
                        <li><strong>Beta-Oxidation:</strong> Ã‡ocuklarda daha aktif pathway</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 9: AntrenmanÄ±n VO2max'a Etkisi -->
            <div class="slide" id="slide9">
                <h2>ğŸ‹ï¸â€â™€ï¸ ANTRENMANIN VOâ‚‚max'A ETKÄ°SÄ°</h2>

                <h3>ğŸ“ˆ Antrenabilirlik Potansiyeli</h3>
                <div class="success-box">
                    <h4>ğŸ’ª 2024 Meta-Analiz SonuÃ§larÄ±</h4>
                    <ul>
                        <li><strong>Ortalama ArtÄ±ÅŸ:</strong> %5-15 (1.5-4.5 ml/kg/dk)</li>
                        <li><strong>En Ä°yi YanÄ±t Grubu:</strong> Normal kilolu, prepubertal Ã§ocuklar</li>
                        <li><strong>Minimum SÃ¼re:</strong> 8 hafta, optimal 12-16 hafta</li>
                        <li><strong>Frekans:</strong> Haftada 3-4 antrenman seansÄ±</li>
                    </ul>
                    
                    <div class="equation">
                        Effect Size: d = 0.52 (orta bÃ¼yÃ¼klÃ¼kte etki)
                    </div>
                </div>

                <div class="detail-box">
                    <h4>ğŸ¯ YaÅŸ GruplarÄ±na GÃ¶re Antrenman YanÄ±tÄ±</h4>
                    <ul>
                        <li><strong>6-9 yaÅŸ:</strong> %8-12 artÄ±ÅŸ (oyun temelli yaklaÅŸÄ±mlar)</li>
                        <li><strong>10-13 yaÅŸ:</strong> %10-15 artÄ±ÅŸ (yapÄ±landÄ±rÄ±lmÄ±ÅŸ antrenman)</li>
                        <li><strong>14-17 yaÅŸ:</strong> %5-10 artÄ±ÅŸ (spor spesifik programlar)</li>
                        <li><strong>Detraining:</strong> 2-4 hafta sonra %50 kayÄ±p</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸ”¬ Antrenman AdaptasyonlarÄ±nÄ±n MekanizmalarÄ±</h4>
                    <ul>
                        <li><strong>Kardiyak Adaptasyonlar:</strong> SV artÄ±ÅŸÄ± (%10-20)</li>
                        <li><strong>Periferik Adaptasyonlar:</strong> a-v Oâ‚‚ farkÄ±nda artÄ±ÅŸ</li>
                        <li><strong>Pulmoner Fonksiyonlar:</strong> Ventilatory efficiency geliÅŸimi</li>
                        <li><strong>Metabolik Adaptasyonlar:</strong> Substrate utilization optimization</li>
                    </ul>
                </div>

                <div class="warning-box">
                    <h4>âš ï¸ Bireysel Varyasyon ve Limitasyonlar</h4>
                    <ul>
                        <li><strong>Genetik FaktÃ¶r:</strong> %40-60 yanÄ±t varyasyonu genetik</li>
                        <li><strong>Non-responders:</strong> Populasyonun %10-20'si minimal yanÄ±t</li>
                        <li><strong>Maturation Status:</strong> Biyolojik yaÅŸ etkisi</li>
                        <li><strong>Training History:</strong> Ã–nceki deneyim etkisi</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 11: SaÄŸlÄ±k ve Klinik Uygulamalar -->
            <div class="slide" id="slide11">
                <h2>ğŸ‘¨â€âš•ï¸ SAÄLIK VE KLÄ°NÄ°K UYGULAMALAR</h2>

                <h3>ğŸ¥ Klinik DeÄŸerlendirmede VOâ‚‚max</h3>
                <div class="detail-box">
                    <h4>ğŸ©º Kardiyopulmoner HastalÄ±klarda</h4>
                    <ul>
                        <li><strong>Konjenital Kalp HastalÄ±ÄŸÄ±:</strong> Fonksiyonel kapasite deÄŸerlendirmesi</li>
                        <li><strong>AstÄ±m ve Solunum HastalÄ±klarÄ±:</strong> Exercise limitation assessment</li>
                        <li><strong>Obesity ve Metabolik Sendrom:</strong> Risk stratifikasyonu</li>
                        <li><strong>Post-operative Recovery:</strong> Rehabilitasyon planlamasÄ±</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>ğŸ’Š Egzersiz ReÃ§etesi ve Dozaj</h4>
                    <ul>
                        <li><strong>Moderate Intensity:</strong> %40-60 VOâ‚‚max (%64-76 HRmax)</li>
                        <li><strong>Vigorous Intensity:</strong> %60-85 VOâ‚‚max (%77-93 HRmax)</li>
                        <li><strong>SÃ¼re:</strong> 30-60 dakika (yaÅŸa gÃ¶re adaptasyon)</li>
                        <li><strong>Frekans:</strong> Haftada minimum 3, optimal 5 gÃ¼n</li>
                    </ul>
                    
                    <div class="equation">
                        MET = VOâ‚‚ (ml/kg/dk) Ã· 3.5
                    </div>
                </div>

                <div class="research-box">
                    <h4>ğŸ”¬ KardiyovaskÃ¼ler Risk FaktÃ¶rleri</h4>
                    <ul>
                        <li><strong>Low CRF Threshold:</strong> <35 ml/kg/dk (adÃ¶lesan)</li>
                        <li><strong>Metabolik Sendrom:</strong> VOâ‚‚max ile inverse korelasyon</li>
                        <li><strong>Ä°nsÃ¼lin Direnci:</strong> HOMA-IR indexi ile iliÅŸki</li>
                        <li><strong>Arterial Stiffness:</strong> PWV measurements ile korelasyon</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ§  NÃ¶rolojik ve Kognitif Faydalar</h4>
                    <ul>
                        <li><strong>Executive Function:</strong> YÃ¼ksek CRF daha iyi kognitif performans</li>
                        <li><strong>Academic Achievement:</strong> Fiziksel fitness-akademik baÅŸarÄ± korelasyonu</li>
                        <li><strong>BDNF Levels:</strong> Brain-derived neurotrophic factor artÄ±ÅŸÄ±</li>
                        <li><strong>Attention and Memory:</strong> Working memory capacity geliÅŸimi</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 12: Okul Temelli Programlar -->
            <div class="slide" id="slide12">
                <h2>ğŸ« OKUL TEMELLÄ° PROGRAMLAR</h2>

                <h3>ğŸ“š MÃ¼fredat Entegre YaklaÅŸÄ±mlar</h3>
                <div class="success-box">
                    <h4>ğŸ¯ 2024 BaÅŸarÄ±lÄ± Program Modelleri</h4>
                    <ul>
                        <li><strong>SPARK Program:</strong> %12 VOâ‚‚max artÄ±ÅŸÄ±, 16 hafta</li>
                        <li><strong>FitnessGram Integration:</strong> SÃ¼rekli assessment ve tracking</li>
                        <li><strong>Active Learning:</strong> Matematik+fiziksel aktivite kombinasyonu</li>
                        <li><strong>Recess Enhancement:</strong> Organized playground activities</li>
                    </ul>
                </div>

                <div class="detail-box">
                    <h4>â±ï¸ Time-Efficient School Programs</h4>
                    <ul>
                        <li><strong>10-Minute Boosts:</strong> Classroom iÃ§i kÄ±sa aktiviteler</li>
                        <li><strong>Active Transport:</strong> Okula yÃ¼rÃ¼me/bisiklet programlarÄ±</li>
                        <li><strong>Stair Climbing:</strong> Merdiven kullanÄ±mÄ± teÅŸviki</li>
                        <li><strong>Dancing Programs:</strong> MÃ¼zik eÅŸliÄŸinde aerobik aktiviteler</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸ‘¥ Grup Dinamikleri ve Motivasyon</h4>
                    <ul>
                        <li><strong>Peer Influence:</strong> Akran desteÄŸi ve sosyal modeling</li>
                        <li><strong>Gamification:</strong> Puan sistemi ve achievement badges</li>
                        <li><strong>Teacher Training:</strong> EÄŸitmen yetkinlik geliÅŸtirme</li>
                        <li><strong>Family Engagement:</strong> Aile katÄ±lÄ±mÄ± ve home activities</li>
                    </ul>
                </div>

                <div class="warning-box">
                    <h4>âš ï¸ Implementation Challenges</h4>
                    <ul>
                        <li><strong>Time Constraints:</strong> Akademik mÃ¼fredat yoÄŸunluÄŸu</li>
                        <li><strong>Space Limitations:</strong> Fiziksel alan kÄ±sÄ±tlamalarÄ±</li>
                        <li><strong>Equipment Needs:</strong> Minimal ekipman gereksinimleri</li>
                        <li><strong>Sustainability:</strong> Uzun dÃ¶nem program sÃ¼rdÃ¼rÃ¼lebilirliÄŸi</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 13: COVID-19 Pandemi Etkileri -->
            <div class="slide" id="slide13">
                <h2>ğŸ¦  COVID-19 PANDEMÄ° ETKÄ°LERÄ°</h2>

                <h3>ğŸ“‰ Fiziksel Fitness'ta Global DÃ¼ÅŸÃ¼ÅŸ</h3>
                <div class="warning-box">
                    <h4>âš ï¸ Pandemi Etkisi BÃ¼yÃ¼klÃ¼ÄŸÃ¼ (2020-2024 Systematic Review)</h4>
                    <ul>
                        <li><strong>VOâ‚‚max DÃ¼ÅŸÃ¼ÅŸÃ¼:</strong> Erkeklerde -2.25, kÄ±zlarda -4.28 puan</li>
                        <li><strong>20mSRT Performance:</strong> %15-25 ortalama dÃ¼ÅŸÃ¼ÅŸ</li>
                        <li><strong>Recovery Time:</strong> Pre-pandemic seviyelerine dÃ¶nÃ¼ÅŸ 18+ ay</li>
                        <li><strong>Sosyoekonomik Fark:</strong> DÃ¼ÅŸÃ¼k gelir grubunda daha fazla etki</li>
                    </ul>
                </div>

                <div class="detail-box">
                    <h4>ğŸ  Lockdown DÃ¶nemindeki DeÄŸiÅŸimler</h4>
                    <ul>
                        <li><strong>Fiziksel Aktivite:</strong> %50-70 oranÄ±nda azalma</li>
                        <li><strong>Ekran SÃ¼resi:</strong> GÃ¼nlÃ¼k 2-3 saat artÄ±ÅŸ</li>
                        <li><strong>Uyku DÃ¼zeni:</strong> Irregular sleep patterns</li>
                        <li><strong>Beslenme:</strong> Processed food consumption artÄ±ÅŸÄ±</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸ”¬ Physiological Impact Mechanisms</h4>
                    <ul>
                        <li><strong>Detraining Effects:</strong> KardiyovaskÃ¼ler deconditioning</li>
                        <li><strong>Muscle Atrophy:</strong> Disuse-induced strength loss</li>
                        <li><strong>Metabolic Changes:</strong> Insulin resistance artÄ±ÅŸÄ±</li>
                        <li><strong>Mental Health:</strong> Depression ve anxiety artÄ±ÅŸÄ±</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>ğŸ’ª Recovery Strategies ve Interventions</h4>
                    <ul>
                        <li><strong>Gradual Return:</strong> Progressive activity resumption</li>
                        <li><strong>Home-Based Programs:</strong> Virtual PE ve online coaching</li>
                        <li><strong>Outdoor Emphasis:</strong> Nature-based activities teÅŸviki</li>
                        <li><strong>Mental Health Support:</strong> Psychological resilience building</li>
                    </ul>
                </div>

                <div class="info-box">
                    <h4>ğŸ“± Technology-Enhanced Solutions</h4>
                    <ul>
                        <li><strong>Fitness Apps:</strong> Age-appropriate exercise programs</li>
                        <li><strong>Virtual Reality:</strong> Immersive activity experiences</li>
                        <li><strong>Wearable Devices:</strong> Activity tracking ve motivation</li>
                        <li><strong>Social Platforms:</strong> Virtual group activities ve challenges</li>
                    </ul>
                </div>
            </div>

            <!-- Slide 14: Gelecek Perspektifleri -->
            <div class="slide" id="slide14">
                <h2>ğŸ”® GELECEK PERSPEKTÄ°FLERÄ°</h2>

                <h3>ğŸš€ Emerging Technologies</h3>
                <div class="info-box">
                    <h4>ğŸ¤– Artificial Intelligence ve Machine Learning</h4>
                    <ul>
                        <li><strong>Personalized Training:</strong> AI-guided exercise prescription</li>
                        <li><strong>Injury Prediction:</strong> Movement pattern analysis</li>
                        <li><strong>Performance Optimization:</strong> Real-time feedback systems</li>
                        <li><strong>Talent Identification:</strong> Predictive modeling for athletic potential</li>
                    </ul>
                </div>

                <div class="success-box">
                    <h4>ğŸ§¬ Genomics ve Precision Medicine</h4>
                    <ul>
                        <li><strong>Genetic Testing:</strong> Personalized training based on genotype</li>
                        <li><strong>Epigenetic Factors:</strong> Environmental influence on gene expression</li>
                        <li><strong>Pharmacogenomics:</strong> Individualized supplement strategies</li>
                        <li><strong>Biomarker Development:</strong> Early detection of overtraining</li>
                    </ul>
                </div>

                <div class="research-box">
                    <h4>ğŸŒ Global Health Initiatives</h4>
                    <ul>
                        <li><strong>WHO Physical Activity Goals:</strong> Universal fitness standards</li>
                        <li><strong>School Policy Changes:</strong> Mandatory PE ve daily activity</li>
                        <li><strong>Urban Planning:</strong> Active transportation infrastructure</li>
                        <li><strong>Healthcare Integration:</strong> Exercise as medicine protocols</li>
                    </ul>
                </div>

                <div class="detail-box">
                    <h4>ğŸ“Š Future Research Directions</h4>
                    <ul>
                        <li><strong>Longitudinal Studies:</strong> Birth cohort fitness tracking</li>
                        <li><strong>Intervention Optimization:</strong> Dose-response relationships</li>
                        <li><strong>Cross-cultural Studies:</strong> Global fitness patterns</li>
                        <li><strong>Environmental Factors:</strong> Climate change impact on fitness</li>
                    </ul>
                </div>

                <div class="formula-box">
                    <strong>2025-2030 Hedefleri:</strong><br>
                    â€¢ %50 Ã§ocuklarda fitness seviye artÄ±ÅŸÄ±<br>
                    â€¢ Teknoloji destekli kiÅŸiselleÅŸtirilmiÅŸ antrenman<br>
                    â€¢ Global saÄŸlÄ±k eÅŸitsizliklerinin azaltÄ±lmasÄ±
                </div>
            </div>

            <div class="controls">
                <button class="btn" id="prevBtn" onclick="changeSlide(-1)">â¬…ï¸ Ã–nceki</button>
                <div class="slide-counter">
                    <span id="slideNumber">1</span> / <span id="totalSlides">15</span>
                </div>
                <button class="btn" id="nextBtn" onclick="changeSlide(1)">Sonraki â¡ï¸</button>
            </div>

            <div class="notes-container">
                <button class="notes-toggle" onclick="toggleNotes()" id="notesToggle">ğŸ“ NotlarÄ± GÃ¶ster</button>
                
                <!-- Notes content for each slide would be added here -->
                <!-- Sample notes for slide 0 -->
                <div class="notes-content" id="notes0" style="display:none;">
                    <h3>ğŸ” SUNUM GENEL BÄ°LGÄ°LERÄ°</h3>
                    
                    <div class="detail-box">
                        <h4>ğŸ“Š AraÅŸtÄ±rma KapsamÄ± ve Metodoloji</h4>
                        <p>Bu sunum, Ã§ocuk ve sporcularda aerobik gÃ¼Ã§ geliÅŸimi konusunda 2020-2024 dÃ¶neminde yayÄ±mlanmÄ±ÅŸ 50'den fazla sistematik derleme, meta-analiz ve uzun dÃ¶nem kohort Ã§alÄ±ÅŸmasÄ±nÄ±n kapsamlÄ± analizini iÃ§ermektedir.</p>
                        
                        <p><strong>BaÅŸlÄ±ca Veri KaynaklarÄ±:</strong></p>
                        <ul>
                            <li>ACSM, IOC, BASES gÃ¼ncel position statements</li>
                            <li>Pediatric Exercise Science dergisi 2023-2024 sayÄ±larÄ±</li>
                            <li>Medicine & Science in Sports & Exercise gÃ¼ncel araÅŸtÄ±rmalarÄ±</li>
                            <li>European Journal of Applied Physiology Ã§ocuk Ã§alÄ±ÅŸmalarÄ±</li>
                            <li>Journal of Sports Sciences aerobic power meta-analizleri</li>
                        </ul>
                    </div>

                    <div class="research-box">
                        <h4>ğŸŒ Global Perspektif ve Ã–rneklem BÃ¼yÃ¼klÃ¼ÄŸÃ¼</h4>
                        <p>Sunumda yer alan araÅŸtÄ±rmalar toplamda 100.000'in Ã¼zerinde Ã§ocuk ve adÃ¶lesan katÄ±lÄ±mcÄ±yÄ± kapsamaktadÄ±r. Ã‡alÄ±ÅŸmalar Kuzey Amerika, Avrupa, Asya-Pasifik ve GÃ¼ney Amerika'dan geniÅŸ bir coÄŸrafi daÄŸÄ±lÄ±m gÃ¶stermektedir.</p>
                        
                        <p><strong>Ã–ne Ã‡Ä±kan BÃ¼yÃ¼k Ã–lÃ§ekli Ã‡alÄ±ÅŸmalar:</strong></p>
                        <ul>
                            <li>HELENA Study: 3000+ Avrupa adÃ¶lesanÄ±</li>
                            <li>IDEFICS Study: 16.000+ Ã§ocuk, 8 Ã¼lke</li>
                            <li>FitnessGram Database: 10 milyon+ test sonucu</li>
                            <li>COVID-19 Impact Studies: 50.000+ Ã§ocuk pandemi analizi</li>
                        </ul>
                    </div>
                </div>

                <!-- Additional notes containers for other slides would be added here -->
                
            </div>
        </div>
    </div>

    <script>
        let currentSlide = 0;
        const totalSlides = 15;

        function showSlide(n) {
            const slides = document.querySelectorAll('.slide');
            const navItems = document.querySelectorAll('.slide-nav li');
            
            if (n >= totalSlides) currentSlide = 0;
            if (n < 0) currentSlide = totalSlides - 1;
            
            slides.forEach(slide => slide.classList.remove('active'));
            navItems.forEach(item => item.classList.remove('active'));
            
            slides[currentSlide].classList.add('active');
            navItems[currentSlide].classList.add('active');
            
            document.getElementById('slideNumber').textContent = currentSlide + 1;
            
            // Hide all notes
            const notes = document.querySelectorAll('.notes-content');
            notes.forEach(note => note.style.display = 'none');
            
            // Reset notes toggle
            const notesToggle = document.getElementById('notesToggle');
            notesToggle.textContent = 'ğŸ“ NotlarÄ± GÃ¶ster';
        }

        function changeSlide(n) {
            currentSlide += n;
            showSlide(currentSlide);
        }

        function toggleNotes() {
            const currentNotes = document.getElementById('notes' + currentSlide);
            const notesToggle = document.getElementById('notesToggle');
            
            if (currentNotes) {
                if (currentNotes.style.display === 'none' || currentNotes.style.display === '') {
                    currentNotes.style.display = 'block';
                    notesToggle.textContent = 'ğŸ“ NotlarÄ± Gizle';
                } else {
                    currentNotes.style.display = 'none';
                    notesToggle.textContent = 'ğŸ“ NotlarÄ± GÃ¶ster';
                }
            }
        }

        // Navigation event listeners
        document.querySelectorAll('.slide-nav li').forEach((item, index) => {
            item.addEventListener('click', () => {
                currentSlide = index;
                showSlide(currentSlide);
            });
        });

        // Keyboard navigation
        document.addEventListener('keydown', (e) => {
            if (e.key === 'ArrowLeft') changeSlide(-1);
            if (e.key === 'ArrowRight') changeSlide(1);
            if (e.key === 'Escape') {
                const notes = document.querySelectorAll('.notes-content');
                notes.forEach(note => note.style.display = 'none');
                document.getElementById('notesToggle').textContent = 'ğŸ“ NotlarÄ± GÃ¶ster';
            }
        });

        // Initialize
        showSlide(0);
        document.getElementById('totalSlides').textContent = totalSlides;
    </script>
</body>
</html>